Viktoriia Slepeniuk

Viktoriia Slepeniuk currently serves as Vice President of Investor Relations at Medicus Pharma Ltd. and Vice President of Investor Relations and Communications at RBx Capital LP, both positions held since September and August 2023, respectively. In addition, Viktoriia has been a Corporate Affairs Manager and Vice President at Parkway Clinical Laboratories, Inc. since March 2019. Previously, Viktoriia worked as a Capital Markets Associate at FSD Pharma Inc. from September 2019 to May 2021 and held various roles at T3 Trading Group, LLC between August 2012 and August 2014. Viktoriia holds a Bachelor's degree in International Relations and Affairs from Chernivci National 'Juriy Fedkovyc' University.